Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artesunate-amodiaquine vs Artemether-lumefantrine for Uncomplicated Malaria in DRC
NCT04618523Phase 4Completed
- Sponsor
- Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate + amodiaquine, artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo. Started Oct 2020; status: completed.
02
Drugs
artesunate + amodiaquineartemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04618523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618523.